Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

European stocks push higher on aquisition news; Dax up 0.77%

Published 04/28/2014, 07:13 AM
Updated 04/28/2014, 07:13 AM
European stocks extend gains, boosted by Astrazeneca buyout reports

Investing.com - European stocks pushed higher on Monday, boosted by news Britain's Astrazeneca could be aquired by U.S. drugmaker Pfizer, while markets continued to eye developments in the Ukraine.

During European afternoon trade, the DJ Euro Stoxx 50 gained 0.74%, France’s CAC 40 climbed 0.51%, while Germany’s DAX advanced 0.77%.

Investors remained cautious as hostilities between Russia and Ukraine continued. On Friday, U.S. Secretary of State John Kerry warned that Washington was ready to step up sanctions on Russia.

The West is accusing Russia of leading a separatist revolt in eastern Ukraine after it annexed Crimea last month.

In a joint statement on Monday, G-7 nations said they would "move swiftly to impose additional sanctions on Russia" because the latter has not moved to comply with the Geneva accord.

Financial stocks turned broadly higher, as French lenders BNP Paribas (BNPP.PARIS) and Societe Generale (SOGN.PARIS) gained 1.23% and 0.23%, while Germany's Deutsche Bank (DBKGn.XETRA) climbed 0.40%.

Among peripheral lenders, Italy's Unicredit (CRDI.MILAN) and Intesa Sanpaolo (ISP.MILAN) gained 0.51% and 1.12% respectively, while Spanish banks Banco Santander (SAN.MADRID) and BBVA (BBVA.MADRID) advanced 0.68% and 0.86%.

Elswhere, Bayer (BAYGN.XETRA) surged 4.33% after the German pharmaceutical and chemicals conglomorate said it is exploring a sale of its $10 billion plastics unit to focus on boosting its health business.

The news came after the company reported a 12% rise in first-quarter profit, helped by new medicines and a rebound at its plastics unit.

In London, FTSE 100 rose 0.33%, still led by Astrazeneca (AZN.LONDON), up 14.63%, after Pfizer (NYSE:PFE) confirmed that it is interested in acquiring the U.K. drugmaker for about £58.8 billion. The acquisition would be one of the largest takeovers in the industry’s history.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Meanwhile, financial stocks turned mixed, as Barclays (BARC.LONDON) inched up 0.01% and HSBC Holdings (HSBA.LONDON) gained 0.46%, while Lloyds Banking (LLOY.LONDON) retreated 0.43% and the Royal Bank of Scotland (RBS.LONDON) plummeted 1.86%.

In the mining sector, stocks remained mostly lower. Bhp Billiton (BLT.LONDON) declined 0.89% and Glencore Xstrata (GLEN.LONDON) lost 1%, while rival company Rio Tinto (RIO.LONDON) saw shares plunge 2.01%.

In the U.S., equity markets pointed to a higher open. The Dow 30 futures pointed to a 0.35% increase, S&P 500 futures signaled a 0.33% rise, while the Nasdaq 100 futures indicated a 0.32% gain.

Later in the day, the U.S. was to release private sector data on pending home sales.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.